This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06947/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/drug/DB06947/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06947/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06947/identifier/drugbank/

Statements

Subject Item
n2:DB06947
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB06947 n10:DB06947
dcterms:title
1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide
adms:identifier
n8:29U n9:25113128 n11:DB06947 n13:99443418
n5:IUPAC-Name
n6:271B6190-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6196-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6195-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6192-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6193-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6194-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B618E-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B618F-363D-11E5-9242-09173F13E4C5 n6:271B618C-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B618D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B619C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B619D-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6197-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6198-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B619A-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6199-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B619B-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B61A2-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B61A4-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B61A5-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B61A1-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B61A0-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B61A3-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6191-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B619E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B619F-363D-11E5-9242-09173F13E4C5